-
How to maintain the safety of medical insurance funds?
Time of Update: 2021-06-04
Song Shigui, deputy director of the Sichuan Provincial Health Commission, introduced that in recent years, the Sichuan Provincial Health Commission has established a joint meeting system with the Provincial Medical Security Bureau and the Provincial Public Security Department to regularly study new situations and problems in fraudulent insurance work.
-
AbbVie's JAK Inhibitor Key Global Phase 3 Results Announced for Treatment of Atopic Dermatitis
Time of Update: 2021-06-04
In December 2020, AbbVie announced the main results of the Heads Up study: in the treatment of adult patients with moderate to severe atopic dermatitis, upatinib reached the primary endpoint of superiority relative to the control drug.
-
Tianyao: Methylprednisolone sodium succinate for injection passed the consistency evaluation
Time of Update: 2021-06-04
Jinyao Pharmaceutical's methylprednisolone sodium succinate for injection obtained drug registration approval issued by the National Medical Products Administration in November 2012.
In March 2019, Jinyao Pharmaceutical submitted a supplementary application for consistency evaluation to the Drug Evaluation Center of the National Medical Products Administration and was accepted.
-
500 million antidepressants!
Time of Update: 2021-06-04
com, May 31, on May 27, the official website of the State Food and Drug Administration showed that Shanghai Shangyao Zhongxi Pharmaceutical’s duloxetine hydrochloride enteric-coated tablets was approved as a supplementary application, and it was the first company to have reviewed the product.
-
"Bethune·Tumor Patient Education" project launched
Time of Update: 2021-06-04
Professor Li Danqing, Department of Thoracic Surgery, Peking Union Medical College Hospital, introduced that a study in the United States showed that if a person smokes 10 to 20 cigarettes a day, the incidence of lung cancer is 15%.
-
No patent compensation period for new drugs approved before May 31!
Time of Update: 2021-06-04
61 527，《》，。，，：2021531（），。，531，5，。 10，《》，《》202161。《》，。《》，，，。，。 ，、、。，。，“”，《》：、、、、，、。 ，、。，“”，：“202010，《》，。，2021531（），。” ，《》。《》，，、、、。，202011272021111。，、、，，。 5，。，，，《》《》，，，。 19 new drugs launched
-
Cinda Biotech obtains exclusive license for ROS1/NTRK inhibitors from Baoyuan Pharmaceuticals in Greater China
Time of Update: 2021-06-04
The trial includes a phase 2 clinical trial in China with indications for NTRK-positive solid tumors, and a phase 2 clinical trial with indications for first-line and second-line ROS1-positive non-small cell lung cancer in the world.
-
Hausen "Erlotinib Hydrochloride Tablets" Approved for Listing
Time of Update: 2021-06-04
On May 31, Hausen's "Erlotinib Hydrochloride Tablets" was approved by the National Medical Products Administration (NMPA), becoming the second domestic generic drug of this variety.
-
Yangtze River's Class 1 new drug "Levoornidazole Disodium Phosphate for Injection" was approved for marketing
Time of Update: 2021-06-04
In addition, levornidazole disodium phosphate has the following advantages over the clinically used ornidazole sodium chloride injection and levornidazole sodium chloride injection: 1) the lipophilicity is enhanced, compared with ornidazole and Levoornidazole has significantly reduced toxicity and prolonged drug metabolism; 2) Impurity studies have shown that it will not produce toxic degradation product 2-methyl-5nitroimidazole; 3) The pH value when it is prepared into an intravenous preparation Around 5.
-
The liberalization of the three-child policy has far-reaching impact in these medical fields...
Time of Update: 2021-06-04
In this regard, since the liberalization of the two-child policy, the National Health Statistics Yearbook data has changed significantly: In 2017, the number of outpatient visits in general hospitals in China was 240 million, the proportion of pediatric outpatients in general outpatient visits increased from 8.
-
Ten thousand mu of honeysuckle in Xinjiang enters the picking season, special industries help rural revitalization
Time of Update: 2021-06-04
(Finish)Herbs medicinal herbs At present, the 20,000 mu of honeysuckle planted in Yuepuhu County, Xinjiang, on the edge of the Taklimakan Desert is in the picking season.
-
WHO puts China's Kexing Covid-19 vaccine on the "emergency use list"
Time of Update: 2021-06-04
WHO puts China's Kexing Covid-19 vaccine on the "emergency use list" WHO puts China's Kexing Covid-19 vaccine on the "Emergency Use List" WHO puts China's Kexing Covid-19 vaccine on
-
Health Commission: 24 new confirmed cases, of which 10 are from the mainland
Time of Update: 2021-06-04
As of 24:00 on June 1, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 346 confirmed cases (including 6 severe cases), a total of 86,164 cured and discharged cases, and a total of 4,636 deaths.
-
Avoid stigmatization WHO uses Greek letters to name mutated new coronavirus
Time of Update: 2021-06-04
Avoid stigmatization WHO uses Greek letters to name mutated new coronavirus Avoid stigmatization WHO uses Greek letters to name mutated new coronavirus avoid stigmatization WHO uses Greek letters to name mutated new coronavirus China News Service, June 1 reported that on May 31, the World Health Organization (WHO) announced that it would use Greek letters to name the mutant new coronavirus to avoid stigmatizing the country that first detected and discovered the mutant virus.
-
Guangdong: Taking multiple measures simultaneously to carry out the publicity and implementation activities of the newly revised "Regulations on the Supervision and Administration of Medical Devices"
Time of Update: 2021-06-04
Regulations and regulations The market supervision bureaus in Zhuhai, Foshan, Jiangmen, Heyuan, Zhaoqing and other places have also carried out various forms of new "Regulations" publicity and implementation training, setting off a new round of enthusiasm for learning the new "Regulations.
-
Zhong Nanshan recommends increasing screening efforts to cut off the transmission chain as soon as possible
Time of Update: 2021-06-04
Zhong Nanshan recommends increasing screening efforts to cut off the transmission chain as soon as possible Zhong Nanshan recommends increasing screening efforts to cut off the tran
-
The heavy policy is coming, these pharmaceutical companies welcome the benefits
Time of Update: 2021-06-04
According to the analysis of the Prospective Industry Research Institute, in 2018, the size of my country's children's drug market has reached nearly 78.
With the implementation of my country's three-child birth policy, the number of newborns has increased, which means that my country's children's medicine market will further expand.
-
The U.S. FDA approves an innovative oral compound drug for the treatment of schizophrenia and bipolar I disorder
Time of Update: 2021-06-04
On June 1, 2021, Alkermes announced that the US FDA has approved its new drug Lybalvi (formerly known as ALKS 3831) for the treatment of adult schizophrenia and bipolar I disorder.
-
Xianju Pharmaceutical Ropivacaine Hydrochloride Injection Passed Consistency Evaluation
Time of Update: 2021-06-04
On June 1, Zhejiang Xianju Pharmaceutical issued an announcement stating that the company had recently received the "Drug Supplementary Application Approval Notice" (notice number: 2021B01595) on ropivacaine hydrochloride injection approved and issued by the National Medical Products Administration.
Large doses can produce surgical anesthesia, while small doses can produce sensory block (analgesia).
-
Zhejiang pharmaceutical company enters 3 billion injections!
Time of Update: 2021-06-04
Recently, the official website of the State Food and Drug Administration showed that Zhejiang Zuoli Pharmaceutical's esomeprazole sodium for injection was approved for production of imitation 6 categories.
